ISS U.S. National Laboratory

Home

Meet the Scientist: Mary Kearns-Jonker

Meet the Scientist: Mary Kearns-Jonker

Dr. Kearns-Jonker studies heart cells in space to improve medical treatments on Earth.

heart illust patrick lynch cc25b

Media Credit: Image courtesy of Patrick Lynch

At Loma Linda University School of Medicine, Dr. Mary Kearns-Jonker studies how microgravity affects human cardiovascular progenitor cells, which share many characteristics with stem cells. Sending these cells to the ISS leads to new discoveries about their function because they alter their behavior in response to microgravity. The ultimate goal is to improve the treatment and prevention of cardiovascular disease—the leading cause of death in the United States.

What Are Cardiovascular Progenitor Cells?

Progenitor cells are similar to stem cells in that they are unspecialized and have the potential to develop into a range of cell types. But unlike stem cells, which can become any cell type—lung, kidney, skin, bone, you name it—progenitor cells can become cells within a limited category such as cardiovascular tissue (heart and blood vessels). Also, progenitor cells cannot multiply limitlessly the way true stem cells can.

Stem cells and progenitor cells are important tools in regenerative medicine. Emerging treatments in this field can use a patient’s own cells repair damaged tissue and even fight tumors. Learning more about these cells through space-based experiments will help biologists grow and manipulate them in labs on Earth.

Explore More

Menu

ISS National Laboratory® is a registered trademark of the National Aeronautics and Space Administration (NASA), used with permission. The ISS National Laboratory® is managed by the Center for the Advancement of Science in Space, Inc. under Cooperative Agreement with NASA. NASA Partner logo is used with permission. © 2011-2023 The Center for the Advancement of Science in Space, Inc., a 501 (c)(3) Corporation.